section name header

Basics ⬇

Outline


BASICS

Overview!!navigator!!

  • Several rare inherited coagulation deficiencies occur in horses:
    • vWD (vWF deficiency)—vWF is involved in platelet adhesion, and this defect results in abnormal platelet adhesion and platelet plug formation
    • Glanzmann thrombasthenia is a deficiency/dysfunction of the platelet glycoprotein IIb/IIIa complex, critical to platelet adhesion and aggregation
    • Hemophilia A (factor VIII deficiency) results in a defect in the intrinsic coagulation pathway, with deficient clot formation
    • Prekallikrein deficiency leads to defective initiation of the intrinsic coagulation pathway as this glycoprotein stimulates activation of factor XII
    • Protein C deficiency results in a hypercoagulable state and thrombotic events, as protein C is a critical coagulation inhibitor

Signalment!!navigator!!

  • Most disorders are inherited in an autosomal recessive pattern and occur in young purebred horses
  • Hemophilia A is most common, and has been diagnosed in Thoroughbred, Standardbred, Quarter Horse, Tennessee Walking Horse, and Arabian colts. It is an X-linked recessive chromosomal abnormality usually evident in colts <6 months of age (up to 3 years)
  • Prekallikrein deficiency has been reported in families of American Miniature and Belgian horses, affecting males and females. Horses with signs are homozygous, while heterozygous horses are asymptomatic
  • vWF deficiency has been reported in young Quarter Horses and Thoroughbreds
  • Glanzmann thrombasthenia has been reported in young and adult horses (Thoroughbred cross; Quarter Horse; Peruvian Paso; Oldenburg)
  • Protein C deficiency has been diagnosed in a Thoroughbred colt

Signs!!navigator!!

There are 3 clinical forms:

  • When the defect affects platelet function or primary hemostasis (e.g. vWF deficiency, Glanzmann thrombasthenia), signs are spontaneous epistaxis or bleeding involving mucosal surfaces and prolonged bleeding after trauma/surgery. Petechiae may be observed
  • When the defect affects clot formation or secondary hemostasis (e.g. hemophilia A), signs are a bleeding tendency with spontaneous hemorrhages or prolonged bleeding after trauma/surgery. Bleeding into body cavities, joints, muscles, and subcutaneously is common
  • When the defect is related to a coagulation inhibitor defect (e.g. protein C deficiency), signs are related to the subsequent hypercoagulable state (thrombosis)

Diagnosis ⬆ ⬇

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

  • Disseminated intravascular coagulation (hemorrhagic form)—clinical signs and plasma d-dimer concentrations may aid differentiation
  • Acquired coagulation defects can be difficult to distinguish from inherited defects
  • Platelet disorders (e.g. thrombocytopenia) can be differentiated by platelet counts or tests of platelet function

CBC/Biochemistry/Urinalysis!!navigator!!

  • Few or no changes in CBC, serum biochemistry, and urinalysis
  • Most affected animals have normal platelet counts, but mild thrombocytopenia may be noted if profuse bleeding has occurred

Other Laboratory Tests!!navigator!!

  • vWD—prolonged TBT, normal to prolonged aPTT, and decreased plasma vWF antigen concentration
  • Glanzmann thrombasthenia—prolonged TBT but normal platelet count, PT, aPTT, and vWF antigen concentration. Platelet aggregation responses are markedly impaired
  • Hemophilia A—prolonged aPTT, normal PT, and reduced plasma factor VIII activity
  • Prekallikrein deficiency—prolonged aPTT, normal PT, and reduced plasma prekallikrein activity
  • Protein C deficiency—reduced plasma protein C activity and/or antigen concentration

Imaging!!navigator!!

Ultrasonography for suspected hematomas, hemothorax, or hemoperitoneum.

Other Diagnostic Procedures!!navigator!!

Cytology can confirm the presence of internal hemorrhage.

Treatment ⬆ ⬇

TREATMENT

Potential treatments focus on restoration of the deficient factor by means of whole blood or plasma transfusions. Owners should be informed that these diseases have no cure.

Medications ⬆ ⬇

MEDICATIONS

Contraindications/Possible Interactions

Other treatments affecting platelet function (e.g. colloids) or coagulation (e.g. heparin) may exacerbate bleeding tendency.

Follow-up ⬆ ⬇

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

Continuous monitoring is indicated due to the risk of recurrent hemorrhage.

Prevention/Avoidance!!navigator!!

  • Affected animals and their parents should not be used for breeding
  • Preoperative blood transfusions may be necessary to reduce intrasurgical and postsurgical risk of bleeding

Expected Course and Prognosis!!navigator!!

There is no cure.

Miscellaneous ⬆ ⬇

Outline


MISCELLANEOUS

Pregnancy/Fertility/Breeding!!navigator!!

N/A

Abbreviations!!navigator!!

  • aPTT = activated partial thromboplastin time
  • PT = prothrombin time
  • TBT = template bleeding time
  • vWD = von Willebrand disease
  • vWF = von Willebrand factor

Suggested Reading ⬆ ⬇

Zimmel DN. Hemostatic disorders. In: Robinson NE, ed. Current Therapy in Equine Medicine, 5e. Philadelphia, PA: Saunders, 2003:351–354.

Author(s) ⬆

Author: Eduard Jose-Cunilleras

Consulting Editors: David Hodgson, Harold C. McKenzie, and Jennifer L. Hodgson

Acknowledgment: The author and editors acknowledge the prior contribution of Luis Monreal.